Metraipolis › archive › dc_e201d4ea8e26
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42218569
- DOI
- 10.1186/s40168-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T01:23:50.176Z
- SHA-256 of the archived text
48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b- Stable URL of this page
https://metraipolis.com/documento/dc_e201d4ea8e26
How to cite
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569 — Europe PMC (en), https://europepmc.org/article/MED/42218569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e201d4ea8e26 (Metraipolis archive dc_e201d4ea8e26, sha256 48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b)
BibTeX
@misc{dce201d4ea8e26,
title = {Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42218569},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e201d4ea8e26; sha256 48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42218569. Agents can read the archived copy with the MCP tool read_document.